180 related articles for article (PubMed ID: 30844286)
1. Protein Nanoparticle Fabrication for Optimized Reticuloendothelial System Evasion and Tumor Accumulation.
Roh YG; Shin SW; Kim SY; Kim S; Lim YT; Oh BK; Um SH
Langmuir; 2019 Mar; 35(11):3992-3998. PubMed ID: 30844286
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation.
Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y
Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488
[TBL] [Abstract][Full Text] [Related]
3. RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy.
Long Q; Zhu W; Guo L; Pu L
Drug Des Devel Ther; 2020; 14():5747-5756. PubMed ID: 33408463
[TBL] [Abstract][Full Text] [Related]
4. Novel Milrinone Nanoformulation for Use in Cardiovascular Diseases: Preparation and in Vitro Characterization.
Lomis N; Gaudreault F; Malhotra M; Westfall S; Shum-Tim D; Prakash S
Mol Pharm; 2018 Jul; 15(7):2489-2502. PubMed ID: 28837343
[TBL] [Abstract][Full Text] [Related]
5. A comparative and systematic approach to desolvation and self-assembly methods for synthesis of piperine-loaded human serum albumin nanoparticles.
Abolhassani H; Shojaosadati SA
Colloids Surf B Biointerfaces; 2019 Dec; 184():110534. PubMed ID: 31627104
[TBL] [Abstract][Full Text] [Related]
6. Redox responsive curcumin-loaded human serum albumin nanoparticles: Preparation, characterization and in vitro evaluation.
Saleh T; Soudi T; Shojaosadati SA
Int J Biol Macromol; 2018 Jul; 114():759-766. PubMed ID: 29567499
[TBL] [Abstract][Full Text] [Related]
7. Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells.
Saleh T; Soudi T; Shojaosadati SA
Int J Biol Macromol; 2019 Jun; 130():109-116. PubMed ID: 30802519
[TBL] [Abstract][Full Text] [Related]
8. Rational design of polysorbate 80 stabilized human serum albumin nanoparticles tailored for high drug loading and entrapment of irinotecan.
Taneja N; Singh KK
Int J Pharm; 2018 Jan; 536(1):82-94. PubMed ID: 29146538
[TBL] [Abstract][Full Text] [Related]
9. Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis.
Iwao Y; Tomiguchi I; Domura A; Mantaira Y; Minami A; Suzuki T; Ikawa T; Kimura SI; Itai S
Eur J Pharm Biopharm; 2018 Apr; 125():141-147. PubMed ID: 29407223
[TBL] [Abstract][Full Text] [Related]
10. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment.
Shen Y; Li W
Drug Des Devel Ther; 2018; 12():2285-2292. PubMed ID: 30087553
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting.
Wang W; Liang H; Sun B; Xu J; Zeng Z; Zhao X; Li Q
J Pharm Sci; 2016 Jun; 105(6):1874-1880. PubMed ID: 27129905
[TBL] [Abstract][Full Text] [Related]
12. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
13. In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration.
Tzameret A; Ketter-Katz H; Edelshtain V; Sher I; Corem-Salkmon E; Levy I; Last D; Guez D; Mardor Y; Margel S; Rotenstrich Y
J Nanobiotechnology; 2019 Jan; 17(1):3. PubMed ID: 30630490
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
15. Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.
Gou Y; Zhang Y; Zhang Z; Wang J; Zhou Z; Liang H; Yang F
Mol Pharm; 2017 Jun; 14(6):1861-1873. PubMed ID: 28471669
[TBL] [Abstract][Full Text] [Related]
16. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
[TBL] [Abstract][Full Text] [Related]
17. Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery.
Piazzini V; Landucci E; D'Ambrosio M; Tiozzo Fasiolo L; Cinci L; Colombo G; Pellegrini-Giampietro DE; Bilia AR; Luceri C; Bergonzi MC
Int J Biol Macromol; 2019 May; 129():267-280. PubMed ID: 30726749
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
19. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors.
Lian B; Wu M; Feng Z; Deng Y; Zhong C; Zhao X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):154-165. PubMed ID: 30686050
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
